PENTOBARBITAL SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Pentobarbital Sodium patents expire, and what generic alternatives are available?
Pentobarbital Sodium is a drug marketed by Lannett, Vitarine, Whiteworth Town Plsn, Bpi Labs, Elkins Sinn, Hikma, and Sagent Pharms Inc. and is included in nine NDAs.
The generic ingredient in PENTOBARBITAL SODIUM is pentobarbital sodium. There are two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the pentobarbital sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pentobarbital Sodium
A generic version of PENTOBARBITAL SODIUM was approved as pentobarbital sodium by SAGENT PHARMS INC on May 23rd, 2016.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PENTOBARBITAL SODIUM?
- What are the global sales for PENTOBARBITAL SODIUM?
- What is Average Wholesale Price for PENTOBARBITAL SODIUM?
Summary for PENTOBARBITAL SODIUM
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 9 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 29 |
| Patent Applications: | 3,622 |
| DailyMed Link: | PENTOBARBITAL SODIUM at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PENTOBARBITAL SODIUM
US Patents and Regulatory Information for PENTOBARBITAL SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lannett | PENTOBARBITAL SODIUM | pentobarbital sodium | CAPSULE;ORAL | 085937-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma | PENTOBARBITAL SODIUM | pentobarbital sodium | INJECTABLE;INJECTION | 203619-001 | Nov 13, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Whiteworth Town Plsn | PENTOBARBITAL SODIUM | pentobarbital sodium | CAPSULE;ORAL | 083338-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sagent Pharms Inc | PENTOBARBITAL SODIUM | pentobarbital sodium | INJECTABLE;INJECTION | 206404-001 | May 23, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Lannett | PENTOBARBITAL SODIUM | pentobarbital sodium | CAPSULE;ORAL | 085915-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Vitarine | PENTOBARBITAL SODIUM | pentobarbital sodium | CAPSULE;ORAL | 083284-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Elkins Sinn | PENTOBARBITAL SODIUM | pentobarbital sodium | INJECTABLE;INJECTION | 083270-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
